Serum Enzyme Activity During Radiotherapy of Malignant Tumours
Author Information
Author(s): L. R. Holsti
Primary Institution: University Central Hospital, Helsinki, Finland
Hypothesis
The study investigates the relationship between serum enzyme activity and the effectiveness of radiotherapy in cancer patients.
Conclusion
The increase in serum enzyme activity during radiotherapy usually indicates a favorable response to treatment, particularly in lung cancer patients.
Supporting Evidence
- The study involved 1000 enzyme determinations on 54 patients.
- LDH and aldolase activity increased to pathological levels in one-third of the patients, mainly in lung cancer cases.
- Normal enzyme activity during treatment did not necessarily indicate a poor radiation response.
Takeaway
Doctors checked the blood of cancer patients to see how certain enzymes changed during treatment, which can help understand how well the treatment is working.
Methodology
The study involved 54 patients undergoing split-course radiotherapy, with serum enzyme levels measured before, during, and after treatment.
Limitations
The study could not establish a clear enzyme curve for all patients, and normal enzyme activity did not always correlate with poor treatment response.
Participant Demographics
The sample included 46 inoperable carcinomas and 8 operated carcinomas, primarily lung cancer patients.
Want to read the original?
Access the complete publication on the publisher's website